Results of a Prospective, Open-label, Phase 4 Study Evaluating the Safety, Efficacy, and Treatment Satisfaction in Adult Immune Thrombocytopenia (ITP) Subjects after Switching to Avatrombopag (AVA) from Eltrombopag (ELT) or Romiplostim (ROMI)

Poster is available to registered attendees only via the ASH annual meeting virtual platform, as per congress regulations. 

Session Name: 311. Disorders of Platelet Number or Function: Clinical and Epidemiological: Poster II

Session Date: Sunday, December 8, 2024  

Presentation Time: 6:00 PM - 8:00 PM  

Location: San Diego Convention Center, Halls G-H

Link to Published Abstract